Inventor · disambiguated record
Mark Quang Nguyen
Also filed as: NGUYEN MARK · NGUYEN MARK Q · NGUYEN MARK QUANG · NGUYEN MARK V
34 granted patents·19 pending applications·304 citations·filing 2000–2018
97Inventor score
Top patents by PatentIndex Score
53 records- 0196US7893105B2Levodopa prodrug mesylate, compositions thereof, and uses thereofXENOPORT INC·Filed 2009·Granted Feb 22, 2011·29 cites·26 claims
- 0296US7563821B2Levodopa prodrug mesylate, compositions thereof, and uses thereofXENOPORT INC·Filed 2006·Granted Jul 21, 2009·30 cites·17 claims
- 0396US7534813B2Levodopa prodrugs, and compositions and uses thereofXENOPORT INC·Filed 2008·Granted May 19, 2009·33 cites·25 claims
- 0495US9295731B2Cleavable drug conjugates, compositions thereof and methods of useNGUYEN MARK QUANG·Filed 2013·Granted Mar 29, 2016·16 cites·10 claims
- 0595US7342131B2Levodopa prodrugs, and compositions and uses thereofXENOPORT INC·Filed 2005·Granted Mar 11, 2008·32 cites·45 claims
- 0694US7671089B2Levodopa prodrugs, and compositions and uses thereofXENOPORT INC·Filed 2007·Granted Mar 2, 2010·24 cites·25 claims
- 0794US7323585B2Levodopa prodrugs, and compositions and uses thereofXENOPORT INC·Filed 2005·Granted Jan 29, 2008·26 cites·38 claims
- 0893US7829592B2Catechol protected levodopa diester prodrugs, compositions, and methods of useXENOPORT INC·Filed 2007·Granted Nov 9, 2010·21 cites·5 claims
- 0992US9532968B1Fumarate compounds, pharmaceutical compositions thereof, and methods of useNGUYEN MARK QUANG·Filed 2015·Granted Jan 3, 2017·6 cites·19 claims
- 1092US9409872B1Fumarate compounds, pharmaceutical compositions thereof, and methods of useNGUYEN MARK QUANG·Filed 2015·Granted Aug 9, 2016·6 cites·13 claims
- 1192US7709527B2Levodopa dimethyl-substituted diester prodrugs compositions, and methods of useXENOPORT INC·Filed 2007·Granted May 4, 2010·15 cites·14 claims
- 1291US7968597B2Levodopa prodrug mesylate, compositions thereof, and uses thereofXENOPORT INC·Filed 2008·Granted Jun 28, 2011·10 cites·11 claims
- 1391US7956212B2Levodopa prodrugs, and compositions and uses thereofXENOPORT INC·Filed 2009·Granted Jun 7, 2011·11 cites·10 claims
- 1490US9394312B1Ibrutinib prodrugs, pharmaceutical compositions thereof, and methods of useNGUYEN MARK QUANG·Filed 2015·Granted Jul 19, 2016·4 cites·14 claims
- 1588US8163958B2Levodopa prodrugs, and compositions and uses thereofXIANG JIA-NING·Filed 2011·Granted Apr 24, 2012·9 cites·14 claims
- 1686US9630918B2Cysteine, N-acetylcysteine, and penicillamine related compounds, pharmaceutical compositions thereof, and methods of useNGUYEN MARK QUANG·Filed 2015·Granted Apr 25, 2017·2 cites·20 claims
- 1785US6372742B1Substituted indole compounds and methods of their useGERON CORP·Filed 2000·Granted Apr 16, 2002·13 cites·30 claims
- 1882US8324273B2Catechol protected levodopa diester prodrugs, compositions, and methods of useXIANG JIA-NING·Filed 2010·Granted Dec 4, 2012·5 cites·5 claims
- 1981US9630917B2Cysteamine prodrugs, pharmaceutical compositions thereof, and methods of useNGUYEN MARK QUANG·Filed 2015·Granted Apr 25, 2017·2 cites·16 claims
- 2080US9963428B1Bucillamine prodrugs, pharmaceutical compositions thereof, and methods of useNGUYEN MARK QUANG·Filed 2017·Granted May 8, 2018·1 cites·17 claims
- 2177US9701656B2Tiopronin prodrugs, pharmaceutical compositions thereof, and methods of useNGUYEN MARK QUANG·Filed 2015·Granted Jul 11, 2017·1 cites·18 claims
- 2274US8324272B2Levodopa dimethyl-substituted diester prodrugs, compositions, and methods of useXIANG JIA-NING·Filed 2010·Granted Dec 4, 2012·2 cites·15 claims
- 2373US8193242B2Levodopa prodrug mesylate, compositions thereof, and uses thereofXIANG JIA-NING·Filed 2011·Granted Jun 5, 2012·1 cites·14 claims
- 2472US9403784B1Fumarate compounds, pharmaceutical compositions thereof, and methods of useNGUYEN MARK QUANG·Filed 2015·Granted Aug 2, 2016·1 cites·20 claims
- 2565US2010004332A1Levodopa Prodrugs, and Compositions and Uses ThereofXENOPORT INC·Filed 2009·Application pending·0 cites
- 2664US10898503B2Cleavable drug conjugates, compositions thereof and methods of useNGUYEN MARK QUANG·Filed 2016·Granted Jan 26, 2021·0 cites·3 claims
- 2761US9290445B2Methods of synthesizing a levodopa ester prodrugRAILLARD STEPHEN P·Filed 2009·Granted Mar 22, 2016·0 cites·24 claims
- 2859US2016143937A1Methods of using cleavable drug conjugates and compositions thereofNGUYEN MARK QUANG·Filed 2016·Application pending·0 cites
- 2958US9925191B2Fumarate compounds, pharmaceutical compositions thereof, and methods of useNGUYEN MARK QUANG·Filed 2016·Granted Mar 27, 2018·0 cites·22 claims
- 3058US2012190861A1Levodopa Prodrugs, and Compositions and Uses ThereofXIANG JIA-NING·Filed 2012·Application pending·0 cites
- 3158US2012296109A1Levodopa Prodrugs, and Compositions and Uses ThereofXIANG JIA-NING·Filed 2012·Application pending·0 cites
- 3255US9598354B2Fumarate compounds, pharmaceutical compositions thereof, and methods of useNGUYEN MARK QUANG·Filed 2015·Granted Mar 21, 2017·0 cites·7 claims
- 3355US2014278800A1Systems, devices, and methods for generating location establishment severity identificationTACO BELL CORP·Filed 2013·Application pending·0 cites
- 3453US2016361315A1Ibrutinib prodrugs, pharmaceutical compositions thereof, and methods of useNGUYEN MARK QUANG·Filed 2016·Application pending·0 cites
- 3552US2017027898A1Fumarate compounds, pharmaceutical compositions thereof, and methods of useNGUYEN MARK QUANG·Filed 2016·Application pending·0 cites
- 3649US9738620B2Trientine prodrugs, pharmaceutical compositions thereof, and methods of useNGUYEN MARK QUANG·Filed 2015·Granted Aug 22, 2017·0 cites·20 claims
- 3747US9533941B2Methods of synthesizing a levodopa ester prodrugXENOPORT INC·Filed 2016·Granted Jan 3, 2017·0 cites·10 claims
- 3846US9695189B2Chemical crosslinkers and compositions thereofNGUYEN MARK QUANG·Filed 2013·Granted Jul 4, 2017·0 cites·9 claims
- 3946US2002115700A1Substituted indole compounds and methods of their useFiled 2002·Application pending·0 cites
- 4045USD911063SLouver slatNGUYEN MARK·Filed 2018·Granted Feb 23, 2021·4 cites·1 claims
- 4144US9597306B1Fumarate compounds, pharmaceutical compositions thereof, and methods of useNGUYEN MARK QUANG·Filed 2015·Granted Mar 21, 2017·0 cites·19 claims
- 4244US2016297770A1Fumarate compounds, pharmaceutical compositions thereof, and methods of useNGUYEN MARK QUANG·Filed 2016·Application pending·0 cites
- 4343US9630934B2Fumarate compounds, pharmaceutical compositions thereof, and methods of useNGUYEN MARK QUANG·Filed 2015·Granted Apr 25, 2017·0 cites·19 claims
- 4442US2017022153A1Fumarate compounds, pharmaceutical compositions thereof, and methods of useNGUYEN MARK QUANG·Filed 2015·Application pending·0 cites
- 4542US2017022149A1Fumarate compounds, pharmaceutical compositions thereof, and methods of useNGUYEN MARK QUANG·Filed 2015·Application pending·0 cites
- 4642US2006114911A1Collection and analysis of route data for "Forward and Reverse" routesAPPLIED EXPERT SYSTEMS INC·Filed 2005·Application pending·0 cites
- 4742US2017008834A1Fumarate compounds, pharmaceutical compositions thereof, and methods of useNGUYEN MARK QUANG·Filed 2015·Application pending·0 cites
- 4842US2017020837A1Fumarate compounds, pharmaceutical compositions thereof, and methods of useNGUYEN MARK QUANG·Filed 2015·Application pending·0 cites
- 4941US2017001952A1Fumarate compounds, pharmaceutical compositions thereof, and methods of useNGUYEN MARK QUANG·Filed 2015·Application pending·0 cites
- 5041US2017001953A1Fumarate compounds, pharmaceutical compositions thereof, and methods of useNGUYEN MARK QUANG·Filed 2015·Application pending·0 cites
Showing the top 50 of 53 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Mark Quang Nguyen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →